Shakuntala’s Path to Becoming SLE-Free
Shakuntala, a 48-year-old woman, has been struggling with Systemic Lupus Erythematosus for five years. Her symptoms began in 2019 and she first experienced joint pain in her fingers. This pain was soon accompanied by a burning sensation in her palms and progressively worsened, affecting her shoulders and knees.
In the same year, she sought medical attention at JAYARAM HOSPITAL in NASHIK, where an ANA test confirmed the diagnosis of SLE. Initially, she was prescribed WYSOLONE 20 MG, but her condition did not improve.
In 2020, she consulted OMKAR HOSPITAL, where she received HCQS 200 mg in addition to WYSOLONE 20 mg. Unfortunately, these treatments did not alleviate her symptoms. Subsequently, she went to MSR HOSPITAL, there they referred her to visit SLNS HOSPITAL for further care. Despite these efforts, Shakuntala continued to struggle with her symptoms and ultimately came to our hospital for help.
At our hospital, we have assembled a multidisciplinary team focused on managing Shakuntala’s SLE. After starting treatment, initially she experienced some improvement. Our approach includes developing a comprehensive treatment plan tailored to her specific needs. We aim to address her symptoms effectively and improve her overall quality of life by utilizing the latest medical treatments and therapies
After four transformative years of naturopathic therapeutics, the SLNS Hospital team is thrilled to announce that we’ve successfully tapered all her medications. Today, we celebrate a remarkable milestone—she is officially non-SLE! This victory is a testament to the power of holistic healing and our dedicated medical team.
| S.No | Present medication | Medication (After Treatment) | Mechanism of the drug |
| 1 | PREDNISOLONE (1-0-1 ½) | Tapered | It binds to the glucocorticoid receptor inhibiting proinflammatory signals and promoting anti-inflammatory signals. |
| 2 | HYDROXYCHLOROQUININE SULPHATE 200 mg (1-0-1) | Tapered | Inhibits protein synthesis in susceptible organisms by inhibiting DNA and RNA polymerase. It also inhibits inflammatory mediators such as IL -1 TNF alpha, prostaglandins. |
MEDICATION TITRATION
Through the incorporation of naturopathic therapeutics, both Prednisolone (initially 1-0-1½) and Hydroxychloroquine Sulphate (200 mg, 1-0-1) were successfully tapered. Prednisolone, which binds to glucocorticoid receptors to inhibit proinflammatory signals and enhance anti-inflammatory responses. Similarly, Hydroxychloroquine, known for inhibiting protein synthesis and reducing inflammation by targeting IL-1, TNF alpha, and prostaglandins, was also tapered. The progression achieved through naturopathy played a significant role in reducing dependency on these medications, highlighting the effectiveness of holistic healing in managing inflammation and autoimmune conditions.
| S.No | PARAMETERS | BEFORE TREATMENT | AFTER TREATMENT |
| 1 | LIPOPROTEIN A | 182 | 73.16 |
| 2 | VITAMIN D | 15.16 | 76.5 |
| 3 | LYMPHOCYTE AC | 4.66 | 2.26 |
| 4 | HBA1C | 7.3 | 5.8 |
| 5 | TESTOSTERONE | <7 | 22.2 |
| 6 | VITAMIN B-12 | 319 | 447 |
| 7 | INSULIN FASTING | 59.2 | 2.97 |
| 8 | TRIGLYCERIDES | 320 | 91 |
| 9 | GGT | 51 | 14.64 |
| 10 | UREA | 55.17 | 21.1 |
| 11 | ANA | 80.08 | 43.41 |
TREATMENT FORECAST
Naturopathic therapeutics have delivered remarkable benefits, significantly improving various health parameters. Shakuntala’s Vitamin B-12 and D levels increased from 319 to 447 and 15.16 to 76.5, respectively, boosting her energy and bone health. Her absolute lymphocyte count, which dropped from 4.66 to 2.26, indicates a more balanced immune system. Blood sugar control improved, as evidenced by a reduction in HBA1C from 7.3 to 5.8. Additionally, testosterone levels were optimized from <7 to 22.2, enhancing overall hormonal balance, while Lipoprotein A levels dropped from 182 to 73.16, significantly reducing cardiovascular risks. These improvements demonstrate the comprehensive benefits of naturopathic treatment in enhancing her overall health and well-being.